TY  - ADVS
AU  - SHIVALEELA M
TI  - Formulation and evaluation of nanoparticles containing Ramipril
U1  - 615.1 
PY  - 2013///
KW  - Pharmaceutics (615.1)
N1  - atenolol ; buccal ; containing ; evaluation ; Formulation ; lipid ; nanoparticles ; Ramipril ; solid ; strips ; Zolmitriptan
ER  -